Heart valve disease gender difference in the era of transcatheter treatment

Cristina Aurigemma, Francesco Burzotta, Carlo Trani

Research output: Contribution to journalArticle

Abstract

Abstract Available data have demonstrated important sex-related differences in patients with valvular heart disease, regarding clinical presentation, treatment, and outcomes. Although the calcific aortic stenosis (AS) is more frequent in men compared to women, the majority of AS patients over 80 years old are women, in whom fibrotic remodeling of aortic valve is typically found. Mitral valve disease is more common in women. However females are under-referred or delayed referrals to treatment, probably due to the absence of sex-based LV dimension values guiding surgical timing. The development of transcatheter devices have revolutionized the treatment of valvular heart disease and increased the interest in this topic. In this context, the consideration of gender differences in presentation, diagnosis, treatment success, and prognosis is of great importance. Copyright ©2023 Heart, Vessels and Transplantation.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalHeart, Vessels and Transplantation
Volume7
DOIs
Publication statusPublished - 2023

Keywords

  • Heart valve disease, transcatheter treatment

Fingerprint

Dive into the research topics of 'Heart valve disease gender difference in the era of transcatheter treatment'. Together they form a unique fingerprint.

Cite this